Navigating Mental Health Care: When to Consider Neurotherapy
Navigating Mental Health Care: When to Consider Neurotherapy By Charles Miller, CRNA, CMO, Founder/Owner of Scenic City Neurotherapy You don’t need another reminder to
Since 2019, we’ve delivered 27,000+ infusions at our dedicated clinic, helping individuals achieve lasting relief from depression, anxiety, PTSD, long-COVID, and many other neurodegenerative conditions.
Why MSKIT®?
✔ Science-Driven — Protocols built on science, proven in practice.
✔ Proven Effective — Our research (2022–2024, 252 patients) shows an 82% response rate.
✔ Safe & Precise — Expert CRNA-led care with optimal dosing for optimal outcomes.
✔ Comfort-Focused — A supportive, patient-first experience.
We’ve administered 1,300+ rTMS treatments and 275+ Accelerated iTBS (SNT) treatments, delivering life-changing results for treatment resistant depression, anxiety, and OCD.
Why TMS at Scenic City Neurotherapy?
✔ Proven Effective – 90%+ response rate with SNT.
✔ Precise – 3D Stim-Guide mapping ensures targeted treatment.
✔ Enhanced Results – TMS can be paired with ketamine boosters for added support.
✔ Safe & Non-Invasive – FDA-cleared, drug-free treatment.
Your comfort and health care needs are our utmost priority. We exclusively employ Certified Registered Nurse Anesthesiologists (CRNAs) to administer ketamine treatments to patients. We promise to put our patient’s safety needs first, providing and delivering exceptional individualized care from assessment, through, and beyond stabilization therapy.
According to a study published in the National Library of Medicine in regards to Ketamine Infusion Therapy, the primary outcome of a randomized controlled trial of a single infusion of ketamine compared to an active placebo was a change in depression severity 24 hours after drug administration, as assessed by the Montgomery-Åsberg Depression Rating Scale (MADRS). The ketamine group had greater improvement in the MADRS score than the midazolam group 24 hours after treatment. After adjustment for baseline scores and site, the MADRS score was lower in the ketamine group than in the midazolam group by 7.95 points (95% confidence interval [CI], 3.20 to 12.71).
See more research and articles on ketamine infusion treatment here.
Established in 2019, Scenic City Neurotherapy is a pioneer in Neurotherapeutic treatments for those struggling with treatment-resistant illnesses, combining cutting-edge therapies with expertise you can trust.
As a registered research location, we lead the way in innovation. MSKIT® consistently demonstrates the highest patient-reported relief of depressive symptoms across all ketamine administration modalities. With over 40 years of combined anesthesia experience and Charles Miller’s role as faculty at University of Tennessee, Chattanooga, our team is committed to your care at the highest level.
At Scenic City Neurotherapy, we believe that brain health is mental health, and we’re here to help you reclaim your life with effective, transformative solutions. If you’re seeking relief from depressive symptoms or chronic pain, we are here to help you reclaim your life.
Navigating Mental Health Care: When to Consider Neurotherapy By Charles Miller, CRNA, CMO, Founder/Owner of Scenic City Neurotherapy You don’t need another reminder to
The Science Behind Transcranial Magnetic Stimulation (TMS) Therapy: Life After Treatment What Happens After TMS? Understanding the Long-Term Impact By Charles Miller, CRNA, CMO, Founder
How to Prepare for Your First TMS Session Understanding Transcranial Magnetic Stimulation (TMS) Therapy By Charles Miller, CRNA, CMO, Founder of Scenic City Neurotherapy
Monday: 9 A.M. – 7 P.M.
Tuesday: 9 A.M. – 7 P.M.
Wednesday: 9 A.M. – 7 P.M.
Thursday: 9 A.M. – 7 P.M.
Friday: 9 A.M. – 7 P.M.
Saturday: We’re Closed
Sunday: 9 A.M. – 7 P.M.
Get 60% + 14 day free trial.
